Drugs / CP-778,875
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00326326 | Jul 2006 → Jun 2007 | hyperlipidemia | Pfizer | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CP-778,875 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00326326 ↗ |
| Action | Activate | “Peroxisome proliferator-activated receptor alpha agonist” CHEMBL5314385 ↗ |
| Modality | Small molecule | — CHEMBL5314385 ↗ |
| Target | PPARA | “Peroxisome proliferator-activated receptor alpha agonist” CHEMBL5314385 ↗ |